Reuters logo
BRIEF-Horizon Pharma Q4 adjusted earnings per share $0.64
2017年2月27日 / 中午12点17分 / 7 个月前

BRIEF-Horizon Pharma Q4 adjusted earnings per share $0.64

Feb 27 (Reuters) - Horizon Pharma Plc

* Horizon pharma plc announces fourth-quarter and full-year 2016 financial results and provides full-year 2017 net sales and adjusted ebitda guidance

* Q4 non-gaap earnings per share $0.64

* Q4 sales $310.3 million versus i/b/e/s view $309.6 million

* Q4 earnings per share view $0.51 -- Thomson Reuters I/B/E/S

* Sees fy 2017 sales $1.24 billion to $1.29 billion

* Q4 gaap loss per share $0.81

* Sees fy 2017 sales up 19 to 23 percent

* Horizon pharma plc sees full-year 2017 adjusted ebitda guidance of $525 million to $575 million Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below